It’s still unclear as to why women participate less in areas like cardiovascular disease, so Van Diemen and her colleagues looked for evidence behind the motivators, facilitators and barriers to trial participation. They only found six studies (including a total of 846 men and 1,122 women) that fit their criteria, according to the paper published in the European Heart Journal.
The primary motivators for enrolment in trials were the possibility of better care, and the altruistic desire to promote science – while barriers such as time constraints and the potential for unfavourable outcomes were also highlighted by both sexes.
However, women appeared to perceive a higher risk of harm from participation versus men,
Women are more risk averse than men. This is long known – see the Lehman Sisters barb from Harriet Harman – so why is anyone surprised?
Seriously, “Hold my beer and watch this” is a gendered phrase after all.